Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Apremilast may help treat hair loss in alopecia areata.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Dermatologists often treat alopecia areata inconsistently, especially in children and advanced cases.

I'm sorry, but without the content of the document, I cannot provide a conclusion. Please provide the text you'd like summarized.

Side effects of drugs can lead to the discovery of new treatments.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Men with male pattern baldness have increased arterial stiffness.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Hair testing is crucial for forensic science and public health.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Non-invasive methods can effectively diagnose and manage alopecia areata.

This is a schedule of hair restoration surgery events.

Accurate diagnosis and understanding of alopecia areata in children are crucial for proper treatment.